Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fernandes

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Health Affairs (Project Hope)|May 14, 2008
Correcting Hatch-WaxmanMichael Fernandes
The Lancet. Oncology|December 7, 2017
Cancer, checkpoint inhibitors, and confusionMichael Fernandes, Jan Brábek
Biotechnology & Genetic Engineering Reviews|October 5, 2006
Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and businessMichael Fernandes, David Miska
The Lancet. Oncology|January 10, 2012
Affordable cancer careJan Brábek, Michael Fernandes
Nature Biotechnology|October 2, 2002
Strategic rethink for German biotechnologyMichael Fernandes, David Miska
Lancet (London, England)|May 17, 2005
Prediction of cancer outcome with microarraysShea N Gardner, Michael Fernandes
Journal of Experimental Therapeutics & Oncology|July 17, 2004
Cytostatic anticancer drug developmentShea N Gardner, Michael Fernandes
Molecular Cancer Therapeutics|October 28, 2003
New tools for cancer chemotherapy: computational assistance for tailoring treatmentsShea N Gardner, Michael Fernandes
American Journal of Ophthalmology|January 5, 2002
Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trialVladimir A Stoy, Michael Fernandes
Lancet (London, England)|February 6, 2007
Haemoglobin concentrations in chronic kidney diseaseMichael Fernandes, Hiroki Sawa, Giuseppe Bellini
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Health Affairs (Project Hope)|May 14, 2008
Correcting Hatch-WaxmanMichael Fernandes
The Lancet. Oncology|December 7, 2017
Cancer, checkpoint inhibitors, and confusionMichael Fernandes, Jan Brábek
Biotechnology & Genetic Engineering Reviews|October 5, 2006
Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and businessMichael Fernandes, David Miska
The Lancet. Oncology|January 10, 2012
Affordable cancer careJan Brábek, Michael Fernandes
Nature Biotechnology|October 2, 2002
Strategic rethink for German biotechnologyMichael Fernandes, David Miska
Lancet (London, England)|May 17, 2005
Prediction of cancer outcome with microarraysShea N Gardner, Michael Fernandes
Journal of Experimental Therapeutics & Oncology|July 17, 2004
Cytostatic anticancer drug developmentShea N Gardner, Michael Fernandes
Molecular Cancer Therapeutics|October 28, 2003
New tools for cancer chemotherapy: computational assistance for tailoring treatmentsShea N Gardner, Michael Fernandes
American Journal of Ophthalmology|January 5, 2002
Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trialVladimir A Stoy, Michael Fernandes
Lancet (London, England)|February 6, 2007
Haemoglobin concentrations in chronic kidney diseaseMichael Fernandes, Hiroki Sawa, Giuseppe Bellini
Pageof 2